Core Viewpoint - The company, Pulaike, plans to acquire a 4.04% stake in Zhongpu Bio held by CITIC Agriculture, with the transfer valuation and minimum transfer price set at 17.5143 million yuan [1] Group 1: Transaction Details - CITIC Agriculture is transferring its 4.04% stake in Zhongpu Bio, which primarily focuses on foot-and-mouth disease vaccine business [1] - Pulaike, Zhongmu Co., and CITIC Agriculture hold 46.97%, 48.99%, and 4.04% stakes in Zhongpu Bio, respectively [1] - Pulaike has the right of first refusal for this stake acquisition [1] Group 2: Corporate Governance - The board of directors of Pulaike has approved the transaction on December 2, 2025, and it does not require shareholder approval [1] - The transaction does not constitute a related party transaction or a major asset restructuring [1] Group 3: Control Implications - If the transaction is completed, Pulaike will gain control over Zhongpu Bio [1]
普莱柯:拟1751.43万元认购中普生物4.04%股权